Posts from 存档:Press Releases


IRISYS Chairman, CEO & Founder Represents Biotech Industry at San Diego US-China Trade Relations Meeting

七月 19th, 2018
– Dr. Jerry Yakatan, Chairman, CEO & Founder of IRI …

Continue Reading


IRISYS To Expand Drug Delivery Technology Capabilities & Services in China

七月 9th, 2018
– IRISYS Announces Joint Venture with Zhejiang Yangtze …

Continue Reading


IRISYS Discussions at CPhI China feature Gerald Yakatan, Ph.D., Chairman, CEO & Founder

六月 19th, 2018
IRISYS to discuss its customized services for international clients at the leading pharmaceutical industry event in China…  


IRISYS’ SCOT-TUSSIN Products will be Exhibited at the 2018 Cardinal Health Retail Business Conference

六月 18th, 2018
Louis Scotti, Division President, will Showcase the SCOT-TUSSIN Sugar-free & Alcohol-free Medicines for Diabetic/Hypertensive Consumers…  


IRISYS Awarded NCATS “CRO Support for Drug Product Development, Manufacture, and Stability Studies” Contract for Up To $14.4 Million

八月 3rd, 2017
– Contract from the National Center for Advancing Trans …

Continue Reading


IRISYS Management is in High Demand at Contract Manufacturing / Packaging / Logistics for Pharmaceuticals & Nutritionals Conference

七月 9th, 2017
– More than 40 life sciences companies request meetings …

Continue Reading


IRISYS Expertise and Asian Outreach Discussed at BIOtech Japan 2017 Conference

六月 21st, 2017
– IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph …

Continue Reading


IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., is a Featured “Innovative Thought Leader” at the 7th Clinical Trials Innovation Programme

五月 10th, 2017
– Dr. Yakatan to Discuss: “Where Have All the New Drugs …

Continue Reading


IRISYS Exhibits at Inaugural CPhI North America Conference

五月 9th, 2017
– Louis Scotti, Vice President, Business Development, l …

Continue Reading


IRISYS Contract with NCI for Manufacturing Clinical Trial Materials is Doubled in Value

四月 20th, 2017
– Award Increased to Up To $6,000,000 Over Five Years – …

Continue Reading


IRISYS to be Represented at CPhI Japan by Chairman, CEO & Founder Gerald Yakatan, Ph.D.

四月 12th, 2017
– Dr. Yakatan will hold meetings to discuss IRISYS’ cus …

Continue Reading


IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., Participates in the 8th Annual Life Science CEO Forum

三月 16th, 2017
– Dr. Yakatan joins discussions with executives from ph …

Continue Reading


IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., Moderates FDA Panel at The International Conference on Drug Development

二月 6th, 2017
– Dr. Yakatan to Direct a Discussion with FDA CDER Lead …

Continue Reading


IRISYS Awarded Long Term Contract by NCI for Manufacturing Clinical Trial Materials

七月 15th, 2015
–Valued at Up To $3,000,000 Over Five Years – SAN DIEGO …

Continue Reading


IRISYS Receives MetroConnect Award & California Competes Tax Credit

七月 10th, 2015
– Helps Support IRISYS Expansion Plans in San Diego and …

Continue Reading